Rajiv Gandhi Centre for Biotechnology

National metagenomic syndromic surveillance NGS hub — Government-designated sequencing hub.

Country: India

Research Institute National metagenomic syndromic surveillance NGS hub

Coverage

	CN	EU	IN	US
diagnostics-medtech	✓	✓	✓	✓

Regulatorsfdaemanmpa

Verifiable facts

Fact	Value	Source
Affiliation	Biotechnology Research and Innovation Council (BRIC), Department of Biotechnology, Government of India	rgcb.res.in
Research focus	Cancer research, cardiovascular disease & diabetes biology, pathogen biology, regenerative biology, neurobiology, reproduction biology, plant biotechnology, transdisciplinary biology, and metagenomic syndromic surveillance	bric.nic.in
Facility	Main Campus (Jagathy), Aakkulam Campus (including BSL-3 facility), BioNest (Kalamassery, Kochi)	rgcb.res.in · bric.nic.in
Grant	Research funding from Bill & Melinda Gates Foundation, International Agency for Research Against Cancer (WHO), National Institutes of Health (USA), Department of Biotechnology, Department of Science & Technology, and Kerala State Council for Science, Technology & Environment	rgcb.res.in
Publications	453 publications (2017-2022)	bric.nic.in
Principal staff	Dr. Beena Pillai (Director), Dr. Radhakrishnan R (Scientist G, Head of LMMD), Dr. Shijulal Nelson Sathi (Scientist E-I)	rgcb.res.in
Headcount	Approximately 40 scientists, 100 research fellows, 71 technical staff, and 23 administrative staff	bric.nic.in

Independent sources: bric.nic.in · rgcb.res.in

Technologies

Name	Cluster	Risk
Genomic pathogen surveillance (service)	diagnostics-medtech	Medium	→

Compiled by BIOECON from primary sources.

Compliance Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.